Cosmetic cross-reference Noindex: medium evidence

81-15-2

CAS 81-15-2

81-15-2 (CAS 81-15-2) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral / FAERS
Adverse signals
0
SOURCE IUPHAR / PharmGKB
PubMed IDs
0
SOURCE ChEMBL 36 B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
81-15-2
CAS Number
81-15-2
UNII
1ZAO16GU5K
InChIKey
XMWRWTSZNLOZFN-UHFFFAOYSA-N
ChEMBL ID
CHEMBL228513
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
MUSK XYLENE
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE RxNorm drug names 1 name row

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
MUSK XYLENE 1921875 SU MTHSPL
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 81-15-2 used for in pharmaceutical contexts?

81-15-2 (CAS 81-15-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 81-15-2?

No adverse-event association or SIDER side-effect rows are rendered for 81-15-2 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 81-15-2 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Musk Xylene with EU status "restricted".

What clinical phase is 81-15-2 in?

No phase 1-4 clinical development badge is rendered for 81-15-2 because the matched compound identifier rows do not contain a max-phase value.